Identification of Small Molecules Exhibiting Oxacillin Synergy through a Novel Assay for Inhibition of vraTSR...

Area of Science:

• Microbiology and Infectious Diseases
• Drug Discovery and Development

Background:

• Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant global health threat due to its resistance to penicillin-class antibiotics.
• The vra operon (vraTSR) in S. aureus regulates responses to cell wall stress, a key factor in antibiotic resistance.
• Existing antibiotics are losing efficacy against evolving MRSA strains, necessitating novel therapeutic approaches.

Purpose of the Study:

• To develop and implement a high-throughput screening (HTS) assay to identify compounds that potentiate oxacillin activity against MRSA.
• To discover novel chemical scaffolds capable of restoring oxacillin efficacy against resistant MRSA strains.
• To validate hit compounds through synergistic, molecular, and structural analyses.

Main Methods:

• Developed a multifaceted cell-based assay for identifying oxacillin potentiators.
• Conducted HTS of 13,840 small molecules from the Life Chemicals library against MRSA.
• Utilized checkerboard assays, RT-PCR for vraR expression, and surface plasmon resonance (SPR) for VraS interaction confirmation.
• Performed structure-activity relationship (SAR) studies on identified hit scaffolds.

Main Results:

• Identified three distinct inhibitor scaffolds that potentiate oxacillin activity against MRSA.
• Validated hits demonstrated synergy with oxacillin, modulated vraR expression, and interacted with VraS.
• SAR studies indicated potential for optimizing compound potency for further development.

Conclusions:

• The study successfully identified novel compounds that can restore oxacillin's effectiveness against MRSA.
• These findings provide a strong foundation for developing new therapeutic strategies to combat MRSA infections.
• The identified scaffolds represent promising leads for future antimicrobial drug development.